Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian F Schoppmann

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Langenbeck'S Archives of Surgery|June 6, 2023
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapyLisa Gensthaler, Gerd Jomrich, Jonas Brugger, et al.
Oncotarget|February 23, 2018
The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junctionGerd Jomrich, Marlene Hollenstein, Maximilian John, et al.
Annals of the New York Academy of Sciences|May 19, 2018
Alternative therapies for GERD: a way to personalized antireflux surgeryErwin Rieder, Martin Riegler, Aleksandar P Simić, et al.
Anticancer Research|July 9, 2011
Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of ViennaMarija Bojic, Ursula Pluschnig, Johannes Zacherl, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2024
Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinomaGerd Jomrich, Winny Yan, Dagmar Kollmann, et al.
Molecular and Clinical Oncology|March 21, 2014
Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractMichael Hejna, Peter Birner, Matthias Preusser, et al.
Anticancer Research|April 30, 2014
A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancerKlaus Sahora, Martin Schindl, Irene Kuehrer, et al.
Cancers|November 9, 2024
Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 AlterationGerd Jomrich, Dagmar Kollmann, Winny Yan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 26, 2015
MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native EpitheliumJennifer Drahos, Katrin Schwameis, Linda D Orzolek, et al.
Endoscopy International Open|July 3, 2015
A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resectionWerner Dolak, Ildiko Mesteri, Reza Asari, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Langenbeck'S Archives of Surgery|June 6, 2023
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapyLisa Gensthaler, Gerd Jomrich, Jonas Brugger, et al.
Oncotarget|February 23, 2018
The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junctionGerd Jomrich, Marlene Hollenstein, Maximilian John, et al.
Annals of the New York Academy of Sciences|May 19, 2018
Alternative therapies for GERD: a way to personalized antireflux surgeryErwin Rieder, Martin Riegler, Aleksandar P Simić, et al.
Anticancer Research|July 9, 2011
Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of ViennaMarija Bojic, Ursula Pluschnig, Johannes Zacherl, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2024
Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinomaGerd Jomrich, Winny Yan, Dagmar Kollmann, et al.
Molecular and Clinical Oncology|March 21, 2014
Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractMichael Hejna, Peter Birner, Matthias Preusser, et al.
Anticancer Research|April 30, 2014
A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancerKlaus Sahora, Martin Schindl, Irene Kuehrer, et al.
Cancers|November 9, 2024
Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 AlterationGerd Jomrich, Dagmar Kollmann, Winny Yan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 26, 2015
MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native EpitheliumJennifer Drahos, Katrin Schwameis, Linda D Orzolek, et al.
Endoscopy International Open|July 3, 2015
A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resectionWerner Dolak, Ildiko Mesteri, Reza Asari, et al.
Pageof 15